Alamar Biosciences Inc expected to post a loss of 33 cents a share - Earnings Preview

Alamar Biosciences

07/08/2026 22:56

Alamar Biosciences Inc ALMR.OQ ALMR.O is expected to  report resultson August 10 for the period ending June 30 2026
The Fremont California-based  company is expected to report revenue of $25.94 million, according to the mean estimate from 5 analysts, based on LSEG data.
​LSEG's mean analyst estimate for Alamar Biosciences Inc is for a loss of 33 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."  
The average consensus recommendation for the advanced medical equipment & technology peer group is also "Buy".​
Wall Street's median 12-month price target for Alamar Biosciences Inc is $32.00, about 13.9% above its last closing price of $28.10
This summary was machine generated August 7 at 21:56 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)